MANGOCEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.491 USD | +6.74% |
|
+123.99% | +78.04% |
| May. 21 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
| May. 21 | Sector Update: Health Care | MT |
Valuation
| Fiscal Period: December | 2023 |
|---|---|
| Capitalization 1 | 5.826 |
| Enterprise Value (EV) 1 | 5.216 |
| P/E ratio | -0.48 x |
| Yield | - |
| Capitalization / Revenue | 7,964,310 x |
| EV / Revenue | 7,129,952 x |
| EV / EBITDA | -644,404 x |
| EV / FCF | -1,827,264 x |
| FCF Yield | -0% |
| Price to Book | 7.66 x |
| Nbr of stocks (in thousands) | 21,040 |
| Reference price 2 | 0.2769 |
| Announcement Date | 4/1/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales | - | 0.008939 | 0.7315 |
| EBITDA | - | -1.988 | -8.094 |
| EBIT 1 | -0.0701 | -1.992 | -8.118 |
| Operating Margin | - | -22,279.7% | -1,109.84% |
| Earnings before Tax (EBT) 1 | -0.0708 | -1.998 | -9.212 |
| Net income 1 | -0.0708 | -1.998 | -9.212 |
| Net margin | - | -22,352.11% | -1,259.4% |
| EPS | - | -0.1850 | -0.5717 |
| Free Cash Flow | - | -0.4892 | -2.854 |
| FCF margin | - | -5,472.91% | -390.2% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 9/26/22 | 2/21/23 | 4/1/24 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | 0.02 | - | - |
| Net Cash position 1 | - | 0.33 | 0.61 |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | -0.49 | -2.85 |
| ROE (net income / shareholders' equity) | - | -669% | -1,327% |
| ROA (Net income/ Total Assets) | - | -243% | -494% |
| Assets 1 | - | 0.8233 | 1.865 |
| Book Value Per Share 2 | -0 | 0.0500 | 0.0400 |
| Cash Flow per Share 2 | 0 | 0.0500 | 0.0300 |
| Capex | - | 0.04 | 0 |
| Capex / Sales | - | 482.18% | 0.48% |
| Announcement Date | 9/26/22 | 2/21/23 | 4/1/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +78.04% | 11.03M | |
| +76.52% | 3.47B | |
| -46.84% | 2.02B | |
| +78.57% | 584M | |
| +8.86% | 468M | |
| -24.89% | 91.12M |
- Stock Market
- Equities
- MGRX Stock
- Financials Mangoceuticals, Inc.
